Inclusion criteria
Item
meets one of the following sets of criteria:
boolean
C1512693 (UMLS CUI [1])
Participation status
Item
classification study:
boolean
C2348568 (UMLS CUI [1])
ALL: date of diagnosis
Item
newly diagnosed all*
boolean
C0023449 (UMLS CUI [1,1])
C2316983 (UMLS CUI [1,2])
Criteria
Item
must have one of the following:
boolean
C0242801 (UMLS CUI [1])
Blasts in bone marrow
Item
≥ 25% blasts in bone marrow
boolean
C1982687 (UMLS CUI [1])
White blood count and blasts
Item
≥ 100,000/μl peripheral blood wbc with ≥ 75% blasts, if bone marrow aspiration is omitted for any reason other than medical contraindication
boolean
C0023508 (UMLS CUI [1])
C0523113 (UMLS CUI [2])
C0398523 (UMLS CUI [3,1])
C0445106 (UMLS CUI [3,2])
White blood count and blasts
Item
≥ 30,000/μl wbc with ≥ 75% blasts, if bone marrow aspiration is omitted because of medical contraindication
boolean
C0023508 (UMLS CUI [1])
C0523113 (UMLS CUI [2])
C0398523 (UMLS CUI [3,1])
C1301624 (UMLS CUI [3,2])
Immunophenotyping and wrights stain morphology
Item
immunophenotype and wright's stain morphology of blast cells consistent with acute lymphocytic leukemia
boolean
C0079611 (UMLS CUI [1])
C0770761 (UMLS CUI [2])
Age
Item
≤ 21 years of age at the time of diagnosis
boolean
C0001779 (UMLS CUI [1])
Participation status
Item
no previous registration on 9900
boolean
C2348568 (UMLS CUI [1])
Bone marrow aspiration and peripheral blood specimen
Item
samples must be sent for local institution and cog reference laboratory studies note: *it is urged that a bone marrow aspiration be performed for every patient with suspected all. however, a marrow is not required for patients with ≥ 100,000/μl peripheral blood wbc and ≥ 75% blasts or for those patients whose clinical condition precludes performing the procedure safely. patients with a medical contraindication to the procedure must be discussed with one of the study coordinators and must have a peripheral blood wbc of ≥ 30,000/μl with ≥ 75% blasts.
boolean
C0398523 (UMLS CUI [1])
C1292451 (UMLS CUI [2])
Induction therapy
Item
induction therapy study:
boolean
C3179010 (UMLS CUI [1])
B-precursor acute lymphoblastic leukemia
Item
patients must have a confirmed diagnosis of b-precursor acute lymphoblastic leukemia
boolean
C1737235 (UMLS CUI [1])
Age and participation status
Item
patients must be 1.001 to 21.999 years at diagnosis note: patients meeting all of the above eligibility criteria are eligible for registration on 9900 whether or not they are to be entered on a cog frontline protocol for treatment of newly diagnosed all. registration on 9900 is required for all legacy pog institution patients in order to be eligible for entry on the following cog all studies, which are either currently open or only temporarily closed: p9407, 9904, 9905, 9907, aall0031 and aall00p2.
boolean
C0001779 (UMLS CUI [1])
C2348568 (UMLS CUI [2])
Patient characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Disease characteristics
Item
see disease characteristics
boolean
C1705348 (UMLS CUI [1])
Concurrent therapy
Item
prior concurrent therapy:
boolean
C0009429 (UMLS CUI [1])
Untreated
Item
previously untreated, with the following exception:
boolean
C0332155 (UMLS CUI [1])
Steroid treatment, physical examination and CBC
Item
steroid treatment* in the 48-hour period just prior to study entry will be allowed provided that a physical examination and cbc with differential were performed immediately prior to beginning steroids and results of both are known note: *patients on chronic steroid treatment for another disease are not eligible for a cog new all protocol.
boolean
C0149783 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
C0031809 (UMLS CUI [2])
C0009555 (UMLS CUI [3])